Top Washington, DC Big Data Companies With Best Stability & Growth (49)

Strong Market Position & Advantage: Evidence indicates OCC is the sole SEC‑registered central counterparty for U.S. exchange‑listed equity options and a designated SIFMU, clearing across essentially all U.S. options venues. This entrenched role underpins scale and network advantages as industry volumes set records.

Strong Revenue Growth: Company materials describe fee changes effective January 1, 2025 and materially higher cleared volumes, with annual reports showing higher revenues and net income in 2025 versus 2024. These factors collectively support a rising revenue trajectory.

Resilient & Sustainable Growth: Operational metrics show multi‑year expansion—cleared contracts increased in 2024 and accelerated in 2025, with early‑2026 months remaining higher year over year. Securities‑lending balances also trended up into 2026, reinforcing momentum.

Strong Revenue Growth: Revenue and test volumes are rising, with 2025 total revenue up year over year to $147.2M, U.S. Galleri revenue up, and more than 185,000 tests sold; quarterly updates also showed double‑digit growth.

Strategic Partnerships: Access expanded through TRICARE coverage, Quest Diagnostics ordering integration, digital‑health channels, and health‑system/EHR integrations, alongside international collaborations such as Samsung and a Canada launch.

Investor Backing & Capital Strength: Funding raised in 2025 and a reported cash balance exceeding $850M provide runway into 2030, supporting continued commercialization and regulatory efforts.

Profitability: Q1 2026 adjusted EPS rose to $3.70 and management raised full‑year adjusted EBIT guidance. Net income is projected at $10.3–$11.7B in 2026, reflecting momentum from higher‑margin mix and execution.

Strong Market Position & Advantage: GM regained U.S. market share leadership with industry‑leading 2025 volumes and continued dominance in full‑size pickups and SUVs. The company also held the No. 2 EV seller position domestically, underscoring breadth across ICE and EV segments.

Investor Backing & Capital Strength: The board authorized $6B in share repurchases and increased the quarterly dividend to $0.18 per share. Capital returns alongside prior buybacks, debt paydown, and ongoing free cash flow signal confidence in cash generation.

Strong Revenue Growth: Reported total net revenue rose from $693.4 million in 2024 to about $1.27 billion in 2025, with Q4 2025 also showing strong year‑over‑year growth. Management guides 2026 revenue to roughly $1.59 billion, indicating continued expansion.

Customer Loyalty & Retention: Disclosed net revenue retention of approximately 126% and total remaining contract value exceeding $1.1 billion signal expanding multi‑year demand. These metrics indicate existing customers are increasing spend and extending commitments.

Strategic Partnerships: Multi‑year collaborations with major pharmas and health systems—including a three‑year, $200 million data/modeling agreement with AstraZeneca/Pathos and an expanded Merck collaboration—support growth in data licensing and AI applications. Partnerships with top‑tier sponsors evidence strong demand for the platform.

Investor Backing & Capital Strength: A $100M minority investment from Blackstone Growth announced in January 2026, corroborated by multiple credible sources and reported as a step-up in valuation, signals robust external capital support. The involvement of a late-stage growth investor is presented as a typical marker of expansion.

Strong Hiring & Retention: Public postings through late 2025–early 2026 show active recruiting for senior roles in data science and media services, indicating investment in delivery capacity and go-to-market. Headcount trajectory and senior hires through 2026 are noted as often leading topline by a few quarters.

Market Expansion: An enterprise client roster and broadened channel mix (social, CTV/streaming, web, direct mail, SMS) are described as consistent with moving up-market and expanding product surface area. These commercialization signals align with scaling sales and delivery.

Strong Revenue Growth: Financial results show sustained top-line expansion, with Optum’s revenues rising from $226.6 billion in 2023 to $253 billion in 2024 and additional year-over-year increases noted in 2025. Growth is attributed to Optum Rx and Optum Health in 2024, with Q2 2025 total revenue of $67.2 billion up from the prior year.

Strong Market Position & Advantage: Market presence spans over 120 million consumers, relationships with most U.S. hospitals and health plans, and top-tier positions in PBM and health analytics. The company is identified as a leading player across healthcare IT and analytics and is widely considered a leader in the industry.

Innovation-Driven Growth: Strategy emphasizes value-based care, technology integration, and advanced analytics leveraging extensive datasets to improve outcomes and efficiency. Recognitions and solutions such as Optum Market Advantage and the integration of Change Healthcare strengthen analytics capabilities and support expansion.

Strong Revenue Growth: Reported results show revenue up 9% in 2025 and 14% in Q1 2026 (11% organic constant currency), with management raising full-year 2026 guidance to 11–12% as-reported growth (8–9% organic constant currency). Growth is led by U.S. Markets, especially Financial Services, with Consumer Interactive and several international regions steady to improving in Q1 2026.

Market Expansion: The majority ownership of Trans Union de Mexico closed in Q1 2026, and guidance embeds roughly 3.5 points of full-year growth from recent acquisitions. Double-digit momentum in core U.S. segments alongside improving trends internationally points to widening geographic and product reach.

Innovation-Driven Growth: Management frames the model as “innovation-led and scalable,” with adjusted EBITDA growing alongside revenue and free-cash-flow priorities reiterated. Product and AI-driven solutions are cited as contributors to sustained, high-single-digit organic expansion.

Strong Revenue Growth: Recent results show FY2025 revenue around $1.9B growing year over year, with Q4 2025 also up. FY2026 guidance of roughly $1.99–$2.05B indicates continued top-line expansion.

Profitability: 2025 flipped to positive GAAP net income with $42.3M for the year and $50.1M in Q4, alongside adjusted EBITDA of $215.5M and strong free cash flow. These results point to improving earnings power and cash generation.

Strategic Partnerships: A long‑term Yahoo agreement underpins open‑web scale while new ties with Microsoft (display), Apple News/Stocks, and CTV extensions with Paramount and LG, plus major publisher wins, broaden distribution and demand.

Strong Revenue Growth: Q4 FY2026 revenue rose 46% year over year to $377.7M and full‑year FY2026 revenue grew 48% to $1.32B. Management guides FY2027 revenue to about $1.60B, signaling continued expansion.

Healthy Cash Flow: Free cash flow improved markedly to $237.8M for FY2026 versus $21.6M in FY2025. Quarterly results also showed positive free cash flow, indicating stronger cash generation alongside growth.

Strong Market Position & Advantage: Independent analyst frameworks (e.g., Gartner MQ 2025; IDC 2025) and industry coverage place the company among leaders in backup/data protection and cyber‑recovery. Large‑enterprise traction is evident with 2,805 customers at $100K+ ARR, up year over year.

Strong Market Position & Advantage: WireScreen is presented as a leader in China-focused corporate intelligence, distinguished by a comprehensive dataset (14M+ companies; 25M+ individuals) and advanced analytics that reveal hidden affiliations and risks. Adoption by multinational corporations, law firms, government agencies, and frequent use in investigative contexts reinforce this position.

Strategic Partnerships: A November 2024 partnership with Quantifind integrates WireScreen’s China corporate data into an AI-driven risk platform, expanding reach into national security and compliance workflows. Such integrations and ecosystem collaborations are cited as signals of growing influence and distribution.

Investor Backing & Capital Strength: Backers include Sequoia Capital and Harpoon Ventures with approximately $18M raised and a PitchBook valuation near $70M, alongside an anticipated Series B. This investor profile and continued operational expansion suggest supportive capital to scale.